A precise free kick lifted the United States to a two-goal cushion against Bosnia and Herzegovina, changing the tone of a tense match and rewarding steady pressure. The strike came
Austin-based Ollin Biosciences has secured an oversubscribed $330 million Series B round to advance therapies for vision-threatening diseases, signaling strong investor interest in eye health innovation. The clinical-stage company disclosed
The hype cycle has a new twist: the best-known US models face fresh limits, while a Chinese long-context model, GLM 5.2 from Z AI, is gaining real traction. My view